In our SN-MM cohort, PI3K-Akt-mTOR pathway activation was also observed in MM cases lacking PIK3CA mutations and showing PTEN expression, indicating a complex genetic and epigenetic basis for this finding [16, 69]. This evidence concerns the gene MTOR and Miyoshi myopathy.